| Literature DB >> 33343680 |
Noura Aoussar1, Fatima Ezzahra Laasri2, Mohammed Bourhia3, Nedeljko Manoljovic4, Rajaa Ait Mhand1, Naima Rhallabi1, Riaz Ullah5, Abdelaaty A Shahat5,6, Omar M Noman5, Fahd A Nasr5, Omer M Almarfadi5, Mohammed El Mzibri2, Perica Vasiljević7, Laila Benbacer2, Fouad Mellouki1.
Abstract
BACKGROUND: Lichens present a complex symbiotic relationship between a filamentous fungus, photoautotrophic partner (algae or cyanobacteria), and bacterial community. The Objective of the Study. This study aimed at investigating the chemical composition and cytotoxic, antioxidant, and antimicrobial activities of acetone extracts of Moroccan Evernia prunastri (E. prunastri), Ramalina farinacea (R. farinacea), and Pseudevernia furfuracea (P. furfuracea). Materials and Methods. The phytochemical analysis was carried out by HPLC-UV. The cytotoxic effect was assessed on human prostate cancer (22RV1), human colon carcinoma (HT-29), human hepatocellular carcinoma (Hep-G2), and Hamster ovarian cancer (CHO) cells lines by WST1 assay. The antioxidant power was assessed by DPPH and FRAP assays. The antibacterial effect was obtained using the broth microdilution method.Entities:
Year: 2020 PMID: 33343680 PMCID: PMC7732381 DOI: 10.1155/2020/8104538
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1HPLC chromatograms of the standards used at 254 nm. EVE—evernic acid, USN—usnic acid, ATR—atranorin, CHL—chloratranorin, PHY—physodalic acid, PRO—protocetraric acid, and FUM—fumaprotocetraric acid.
Figure 2HPLC chromatograms of extracts of Pseudevernia furfuracea (a), Evernia prunastri (b), and Ramalina farinacea (c) at 254 nm.
Figure 3The chemical structures of the identified compounds.
Figure 4: Percentage of cell viability of CHO, HT-29, HEP-G2, and 22RV1 cell lines treated with varying concentrations of extracts of P. furfuracea (P.F), R. farinacea (R.F), and E. prunastri (E.P) for 72 h.
Figure 5Morphological aspects of HT-29 cells before (Control) and after 72 h treatment with acetone extract of R. farinacea, E. prunastri, and P. furfuracea with 12.5 µg/mL and 200 µg/mL concentrations and with DMSO at 200 µg/mL.
IC50 values of growth inhibitory effects of R. farinacea, E. prunastri, and P. furfuracea versus CHO, HT-29, Hep-G2, and 22RV1 cell lines at exposure time 72 h.
| Lichen species | Growth inhibitory effects (IC50 ( | |||
|---|---|---|---|---|
| CHO | HT-29 | Hep-G2 | 22RV1 | |
|
| 63.60 ± 2.98a | 57.10 ± 2.83a | 68.60 ± 3.77a | 42.30 ± 2.55a |
|
| 60.80 ± 0.36a | 105.52 ± 0.79b | 95.71 ± 1.50ab | 103.80 ± 18.40a |
|
| 140.24 ± 10.40b | 127.677 ± 5.835c | 110.15 ± 18.50b | 96.42 ± 16.40a |
| Mytomicine | 3.80 ± 0.10c | 0.90 ± 0.10d | 3.21 ± 2.40c | 2.56 ± 0.10b |
Data are expressed in means (n = 3) ± SD. Values reported in the same column with different letters (a–d) significantly differ at p < 0.05.
Total phenolic and flavonoids contents in R. farinacea, E. prunastri, and P. furfuracea extracts.
| Lichen species | TPC ( | TFC ( |
|---|---|---|
|
| 167.67 ± 50.20 | 17.63 ± 1.11∗ |
|
| 194.33 ± 7.50 | 13.50 ± 2.14 |
|
| 328.67 ± 26.81∗∗ | 12.23 ± 0.40 |
Data are reported as mean (n = 3) ± SD, ∗: p < 0.05, ∗∗:p < 0.01.
Figure 6Reducing power of the lichens R. farinacea (R.F), E. prunastri (E.P), and P. furfuracea (P.F) extracts (a) and ascorbic acid and Trolox (b).
Figure 7Scavenging effect of standards, ascorbic acid, and Trolox (a) and P. furfuracea (P.F), E. prunastri (E.P), and R. farinacea (R.F) (b).
IC50 values of crude extracts of R. farinacea, E. prunastri, and P. furfuracea.
| Species | IC50 ( |
|---|---|
|
| >1000 |
|
| >1000 |
|
| 498.40 ± 44.14 |
| Ascorbic acid | 8.90 ± 0.10∗∗ |
| Trolox | 17.83 ± 0.50∗ |
Data are reported as mean (n = 3) ± SD, ∗: p < 0.05, ∗∗:p < 0.01.
In vitro antibacterial effect of crude extracts of P. furfuracea, E. prunastri, and R. farinacea.
| Bacteria |
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|
| MICa | MBCa | MBC/MIC | MICa | MBCa | MBC/MIC | MICa | MBCa | MIC/MBC | |
|
| 0.078 | 0.625 | 8.012 | 0.078 | 1.25 | 16.025 | 0.078 | 0.625 | 8.012 |
|
| 0.31 | 0.625 | 2.016 | 0.625 | 2.5 | 4 | 0.31 | 1.25 | 4.032 |
|
| 0.078 | 0.625 | 8.012 | 0.078 | 0.625 | 8.012 | 0.15 | 1.25 | 8.333 |
| MRSA N°1 | 0.039 | 0.625 | 16.02 | 0.039 | 0.625 | 16.02 | 0.15 | 0.625 | 4.16 |
| MRSA N°2 | 0.15 | 0.625 | 4.16 | 0.15 | 1.25 | 8.33 | 0.625 | 1.25 | 2 |
| MRSA N°3 | 0.078 | 0.625 | 8.01 | 0.15 | 1.25 | 8.33 | 0.625 | 1.25 | 2 |
| MRSA N°4 | 0.15 | 0.625 | 4.16 | 0.15 | 0.625 | 4.16 | 0.625 | 1.25 | 2 |
| MRSA N°5 | 0.078 | 0.625 | 8.012 | 0.15 | 0.625 | 4.16 | 0.625 | 1.25 | 2 |
|
| >25 | — | — | >25 | — | — | >25 | — | — |
|
| >25 | — | — | >25 | — | — | >25 | — | — |
|
| >25 | — | — | >25 | — | — | >25 | — | — |
a: (mg/mL), MRSA: Methicillin-Resistant Staphylococcus aureus.